Le SIDA en Afrique subsaharienne (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

HIV Infections (drug therapy) And NotDavid Coetzee

List of bibliographic references

Number of relevant bibliographic references: 215.
Ident.Authors (with country if any)Title
000013 Dami Collier [Royaume-Uni] ; Collins Iwuji [Afrique du Sud, Royaume-Uni] ; Anne Derache [Afrique du Sud, France] ; Tulio De Oliveira [Afrique du Sud] ; Nonhlanhla Okesola [Afrique du Sud] ; Alexandra Calmy [Suisse] ; Francois Dabis [France] ; Deenan Pillay [Royaume-Uni, Afrique du Sud] ; Ravindra K. Gupta [Royaume-Uni, Afrique du Sud]Virological Outcomes of Second-line Protease Inhibitor–Based Treatment for Human Immunodeficiency Virus Type 1 in a High-Prevalence Rural South African Setting: A Competing-Risks Prospective Cohort Analysis
000022 Morten Skovdal [Danemark] ; Alison Wringe [Royaume-Uni] ; Janet Seeley [Royaume-Uni] ; Jenny Renju [Royaume-Uni] ; Sara Paparini [Royaume-Uni] ; Joyce Wamoyi [Tanzanie] ; Mosa Moshabela [Afrique du Sud] ; William Ddaaki [Ouganda] ; Constance Nyamukapa [Zimbabwe] ; Kenneth Ondenge [Kenya] ; Sarah Bernays [Royaume-Uni] ; Oliver Bonnington [Royaume-Uni]Using theories of practice to understand HIV-positive persons varied engagement with HIV services: a qualitative study in six Sub-Saharan African countries.
000030 Charles Lyons [Afrique du Sud] ; Yogan PillayUnderstanding the Role and Impact of Effective Country and Community Leadership in Progress Toward the Global Plan.
000034 Kate Clouse [États-Unis] ; Tamsin Phillips [Afrique du Sud] ; Landon Myer [Afrique du Sud]Understanding data sources to measure patient retention in HIV care in sub-Saharan Africa.
000038 Nesri Padayatchi [Afrique du Sud] ; Naressa Naidu [Afrique du Sud] ; Gerald Friedland [États-Unis] ; Kasavan Naidoo [Afrique du Sud] ; Francesca Conradie [Afrique du Sud] ; Kogieleum Naidoo [Afrique du Sud] ; Max Roe O'Donnell [États-Unis]Turning the tide against tuberculosis.
000044 Mosa Moshabela [Afrique du Sud] ; Dominic Bukenya [Ouganda] ; Gabriel Darong [Afrique du Sud] ; Joyce Wamoyi [Tanzanie] ; Estelle Mclean [Malawi] ; Morten Skovdal [Danemark] ; William Ddaaki [Ouganda] ; Kenneth Ondeng'E [Kenya] ; Oliver Bonnington [Royaume-Uni] ; Janet Seeley [Afrique du Sud] ; Victoria Hosegood [Afrique du Sud] ; Alison Wringe [Royaume-Uni]Traditional healers, faith healers and medical practitioners: the contribution of medical pluralism to bottlenecks along the cascade of care for HIV/AIDS in Eastern and Southern Africa.
000045 Carolyn M. Audet [États-Unis] ; Sizzy Ngobeni [Afrique du Sud] ; Ryan G. Wagner [Afrique du Sud]Traditional healer treatment of HIV persists in the era of ART: a mixed methods study from rural South Africa.
000048 Olalekan A. Uthman [Afrique du Sud] ; Jean B. Nachega [États-Unis] ; Jean Anderson [États-Unis] ; Steve Kanters [Canada] ; Edward J. Mills [Canada] ; Françoise Renaud [Suisse] ; Shaffiq Essajee [Suisse] ; Meg C. Doherty [Suisse] ; Lynne M. Mofenson [États-Unis]Timing of initiation of antiretroviral therapy and adverse pregnancy outcomes: a systematic review and meta-analysis.
000049 David I. Dolling [Royaume-Uni] ; Ruth L. Goodall [Royaume-Uni] ; Michael Chirara [Zimbabwe] ; James Hakim [Zimbabwe] ; Peter Nkurunziza [Ouganda] ; Paula Munderi [Ouganda] ; David Eram [Ouganda] ; Dinah Tumukunde [Ouganda] ; Moira J. Spyer [Royaume-Uni] ; Charles F. Gilks [Australie] ; Pontiano Kaleebu [Ouganda] ; David T. Dunn [Royaume-Uni] ; Deenan Pillay [Afrique du Sud]The virological durability of first-line ART among HIV-positive adult patients in resource limited settings without virological monitoring: a retrospective analysis of DART trial data.
000053 Stella C. Sabi [Afrique du Sud] ; Mark Rieker [Afrique du Sud]The role of civil society in health policy making in South Africa: a review of the strategies adopted by the Treatment Action Campaign.
000063 Pascal Geldsetzer [États-Unis] ; Joel M. Francis [Tanzanie, États-Unis] ; Nzovu Ulenga [Tanzanie] ; David Sando [États-Unis] ; Irene A. Lema [Tanzanie] ; Eric Mboggo [Tanzanie] ; Maria Vaikath [États-Unis] ; Happiness Koda [Tanzanie] ; Sharon Lwezaula [Tanzanie] ; Janice Hu [États-Unis] ; Ramadhani A. Noor [États-Unis, Tanzanie] ; Ibironke Olofin [États-Unis] ; Elysia Larson [États-Unis] ; Wafaie Fawzi [États-Unis] ; Till B Rnighausen [États-Unis, Allemagne, Afrique du Sud]The impact of community health worker-led home delivery of antiretroviral therapy on virological suppression: a non-inferiority cluster-randomized health systems trial in Dar es Salaam, Tanzania
000081 Shilpee Sharma [Inde] ; Shambhu G. Aralaguppe [Inde] ; Melissa-Rose Abrahams [Afrique du Sud] ; Carolyn Williamson [Afrique du Sud] ; Clive Gray [Afrique du Sud] ; Pachamuthu Balakrishnan [Inde] ; Shanmugam Saravanan [Inde] ; Kailapuri G. Murugavel [Inde] ; Suniti Solomon [Inde] ; Udaykumar Ranga [Inde]The PTAP sequence duplication in HIV-1 subtype C Gag p6 in drug-naive subjects of India and South Africa.
000090 Liam Bell [Afrique du Sud] ; Janique M. Peyper [Afrique du Sud] ; Shaun Garnett [Afrique du Sud] ; Rabecca Tadokera [Afrique du Sud] ; Robert Wilkinson [Royaume-Uni] ; Graeme Meintjes [Afrique du Sud] ; Jonathan M. Blackburn [Afrique du Sud]TB-IRIS: Proteomic analysis of in vitro PBMC responses to Mycobacterium tuberculosis and response modulation by dexamethasone.
000127 Dinberu Seyoum [Belgique] ; Jean-Marie Degryse [Belgique] ; Yehenew Getachew Kifle [Afrique du Sud] ; Ayele Taye [Éthiopie] ; Mulualem Tadesse [Éthiopie] ; Belay Birlie [Éthiopie] ; Akalu Banbeta [Éthiopie] ; Angel Rosas-Aguirre [Belgique] ; Luc Duchateau [Belgique] ; Niko Speybroeck [Belgique]Risk Factors for Mortality among Adult HIV/AIDS Patients Following Antiretroviral Therapy in Southwestern Ethiopia: An Assessment through Survival Models.
000135 Eric H. Decloedt [Afrique du Sud] ; Maia Lesosky [Afrique du Sud] ; Gary Maartens [Afrique du Sud] ; John A. Joska [Afrique du Sud]Renal safety of lithium in HIV-infected patients established on tenofovir disoproxil fumarate containing antiretroviral therapy: analysis from a randomized placebo-controlled trial.
000160 Niren Ray Maharaj [Afrique du Sud] ; Alisa Phulukdaree [Afrique du Sud] ; Savania Nagiah [Afrique du Sud] ; Prithiksha Ramkaran [Afrique du Sud] ; Charlette Tiloke [Afrique du Sud] ; Anil Amichund Chuturgoon [Afrique du Sud]Pro-Inflammatory Cytokine Levels in HIV Infected and Uninfected Pregnant Women with and without Preeclampsia.
000176 Rachel Arnesen [États-Unis] ; Anthony P. Moll [Afrique du Sud] ; Sheela V. Shenoi [États-Unis]Predictors of loss to follow-up among patients on ART at a rural hospital in KwaZulu-Natal, South Africa.
000184 Stephanie Bispo [Royaume-Uni] ; Lana Chikhungu [Royaume-Uni] ; Nigel Rollins [Suisse] ; Nandi Siegfried [Afrique du Sud] ; Marie-Louise Newell [Royaume-Uni]Postnatal HIV transmission in breastfed infants of HIV-infected women on ART: a systematic review and meta-analysis.
000190 Sampson Antwi [Ghana] ; Hongmei Yang [États-Unis] ; Anthony Enimil [Ghana] ; Anima M. Sarfo [Ghana] ; Fizza S. Gillani [États-Unis] ; Daniel Ansong [Ghana] ; Albert Dompreh [Ghana] ; Antoinette Orstin [Ghana] ; Theresa Opoku [Ghana] ; Dennis Bosomtwe [Ghana] ; Lubbe Wiesner [Afrique du Sud] ; Jennifer Norman [Afrique du Sud] ; Charles A. Peloquin [États-Unis] ; Awewura Kwara [États-Unis]Pharmacokinetics of the First-Line Antituberculosis Drugs in Ghanaian Children with Tuberculosis with or without HIV Coinfection.
000210 John Gregson [Royaume-Uni] ; Pontiano Kaleebu [Ouganda] ; Vincent C. Marconi [États-Unis] ; Cloete Van Vuuren [Afrique du Sud] ; Nicaise Ndembi [Nigeria] ; Raph L. Hamers [Pays-Bas] ; Phyllis Kanki [États-Unis] ; Christopher J. Hoffmann [États-Unis] ; Shahin Lockman [États-Unis] ; Deenan Pillay [Afrique du Sud] ; Tulio De Oliveira [Afrique du Sud] ; Nathan Clumeck [Belgique] ; Gillian Hunt [Afrique du Sud] ; Bernhard Kerschberger [Swaziland] ; Robert W. Shafer [États-Unis] ; Chunfu Yang [États-Unis] ; Elliot Raizes [États-Unis] ; Rami Kantor [États-Unis] ; Ravindra K. Gupta [Afrique du Sud]Occult HIV-1 drug resistance to thymidine analogues following failure of first-line tenofovir combined with a cytosine analogue and nevirapine or efavirenz in sub Saharan Africa: a retrospective multi-centre cohort study.
000212 Win Lei Aye [Thaïlande] ; Apa Puckpinyo [Thaïlande] ; Karl Peltzer [Afrique du Sud]Non-adherence to anti-retroviral therapy among HIV infected adults in Mon State of Myanmar.
000218 G. Murphy [Royaume-Uni] ; C D Pilcher [États-Unis] ; S M Keating [États-Unis] ; R. Kassanjee [Afrique du Sud] ; S N Facente [États-Unis] ; A. Welte [Afrique du Sud] ; E. Grebe [Afrique du Sud] ; K. Marson [États-Unis] ; M P Busch [États-Unis] ; P. Dailey [Suisse] ; N. Parkin [Suisse] ; J. Osborn [Suisse] ; S. Ongarello [Suisse] ; K. Marsh [Suisse] ; J M Garcia-Calleja [Suisse]Moving towards a reliable HIV incidence test - current status, resources available, future directions and challenges ahead.
000221 Elizabeth S. Mayne [Afrique du Sud] ; Jaya A. GeorgeMortal allies: human immunodeficiency virus and noncommunicable diseases.
000231 Alyssa C. Mooney [États-Unis] ; Ann Gottert ; Nomhle Khoza [Afrique du Sud] ; Dumisani Rebombo [Afrique du Sud] ; Jennifer Hove [Afrique du Sud] ; Aimée Julien Suárez [États-Unis] ; Rhian Twine [Afrique du Sud] ; Catherine Macphail [Afrique du Sud] ; Sarah Treves-Kagan [États-Unis] ; Kathleen Kahn [Afrique du Sud] ; Audrey Pettifor [Afrique du Sud] ; Sheri A. Lippman [Afrique du Sud]Men's Perceptions of Treatment as Prevention in South Africa: Implications for Engagement in HIV Care and Treatment.
000245 Amy L. Slogrove [Afrique du Sud] ; Mary Mahy [Suisse] ; Alice Armstrong [Royaume-Uni] ; Mary-Ann Davies [Afrique du Sud]Living and dying to be counted: What we know about the epidemiology of the global adolescent HIV epidemic.
000251 Steve Innes [Afrique du Sud] ; Ronald Van Toorn ; Kennedy Otwombe ; Els Dobbels ; Gert Van Zyl ; Mark F. Cotton ; Barbara LaughtonLate-Onset Hiv Encephalopathy In Children With Long-Standing Virologic Suppression Followed By Slow Spontaneous Recovery Despite no Change In Antiretroviral Therapy: 4 Case Reports.
000254 Awoke Seyoum [Éthiopie] ; Principal Ndlovu [Afrique du Sud] ; Zewotir Temesgen [Afrique du Sud]Joint longitudinal data analysis in detecting determinants of CD4 cell count change and adherence to highly active antiretroviral therapy at Felege Hiwot Teaching and Specialized Hospital, North-west Ethiopia (Amhara Region).
000255 Moleen Zunza [Afrique du Sud] ; Diane M. Gray ; Taryn Young ; Mark Cotton ; Heather J. ZarIsoniazid for preventing tuberculosis in HIV-infected children.
000261 Jennifer Onwumeh ; Charles I. Okwundu ; Tamara Kredo [Afrique du Sud]Interleukin-2 as an adjunct to antiretroviral therapy for HIV-positive adults.
000274 Mhairi Maskew [Afrique du Sud] ; Jacob Bor [Afrique du Sud] ; Cheryl Hendrickson [Afrique du Sud] ; William Macleod [Afrique du Sud] ; Till B Rnighausen [Afrique du Sud] ; Deenan Pillay [Afrique du Sud] ; Ian Sanne [Afrique du Sud] ; Sergio Carmona [Afrique du Sud] ; Wendy Stevens [Afrique du Sud] ; Matthew P. Fox [Afrique du Sud]Imputing HIV treatment start dates from routine laboratory data in South Africa: a validation study.
000275 Timothy Johan Tucker [Afrique du Sud] ; Peter Tsakani ManyikeImproving the clinic-laboratory-interface in the context of HIV diagnosis, treatment, and monitoring.
000277 Karl-Günter Technau [Afrique du Sud] ; Louise Kuhn [États-Unis] ; Ashraf Coovadia [Afrique du Sud] ; Sergio Carmona [Afrique du Sud] ; Gayle Sherman [Afrique du Sud]Improving early identification of HIV-infected neonates with birth PCR testing in a large urban hospital in Johannesburg, South Africa: successes and challenges.
000278 Jessica E. Haberer [États-Unis] ; Lora Sabin [États-Unis] ; K Rivet Amico [États-Unis] ; Catherine Orrell [Afrique du Sud] ; Omar Galárraga [États-Unis] ; Alexander C. Tsai [États-Unis] ; Rachel C. Vreeman [États-Unis] ; Ira Wilson [États-Unis] ; Nadia A. Sam-Agudu [Nigeria] ; Terrence F. Blaschke [États-Unis] ; Bernard Vrijens [Belgique] ; Claude A. Mellins [États-Unis] ; Robert H. Remien [États-Unis] ; Sheri D. Weiser [États-Unis] ; Elizabeth Lowenthal [États-Unis] ; Michael J. Stirratt [États-Unis] ; Papa Salif Sow [États-Unis] ; Bruce Thomas [États-Unis] ; Nathan Ford [Suisse] ; Edward Mills [Canada] ; Richard Lester ; Jean B. Nachega [États-Unis] ; Bosco Mwebesa Bwana [Ouganda] ; Fred Ssewamala [États-Unis] ; Lawrence Mbuagbaw [Canada] ; Paula Munderi [Ouganda] ; Elvin Geng [États-Unis] ; David R. Bangsberg [États-Unis]Improving antiretroviral therapy adherence in resource-limited settings at scale: a discussion of interventions and recommendations.
000292 Kathryn Church [Royaume-Uni] ; Kazuyo Machiyama [Royaume-Uni] ; Jim Todd [Royaume-Uni] ; Brian Njamwea [Kenya] ; Mary Mwangome ; Vicky Hosegood [Royaume-Uni] ; Janet Michel [Afrique du Sud] ; Samuel Oti [Kenya] ; Constance Nyamukapa [Zimbabwe] ; Amelia Crampin [Royaume-Uni] ; Nyaguara Amek [Kenya] ; Gertrude Nakigozi [Ouganda] ; Denna Michael [Tanzanie] ; F Xavier G Mez-Olivé [Afrique du Sud] ; Jessica Nakiyingi-Miiro [Ouganda] ; Basia Zaba [Royaume-Uni] ; Alison Wringe [Royaume-Uni]Identifying gaps in HIV service delivery across the diagnosis-to-treatment cascade: findings from health facility surveys in six sub-Saharan countries.
000305 Kogieleum Naidoo [Afrique du Sud] ; Razia Hassan-Moosa [Afrique du Sud] ; Nonhlanhla Yende-Zuma [Afrique du Sud] ; Dhineshree Govender [Afrique du Sud] ; Nesri Padayatchi [Afrique du Sud] ; Halima Dawood [Afrique du Sud] ; Rochelle Nicola Adams [Afrique du Sud] ; Aveshen Govender [Afrique du Sud] ; Tilagavathy Chinappa [Afrique du Sud] ; Salim Abdool-Karim [Afrique du Sud] ; Quarraisha Abdool-Karim [Afrique du Sud]High mortality rates in men initiated on anti-retroviral treatment in KwaZulu-Natal, South Africa.
000310 Connie Celum [États-Unis] ; Ting Hong [États-Unis] ; Anne Cent [États-Unis] ; Deborah Donnell [États-Unis] ; Rhoda Morrow [États-Unis] ; Jared M. Baeten [États-Unis] ; Cynthia Firnhaber [Afrique du Sud] ; Beatriz Grinsztejn [Brésil] ; Mina C. Hosseinipour [Malawi] ; Umesh Lalloo [Afrique du Sud] ; Mulinda Nyirenda [Malawi] ; Cynthia Riviere [Haïti] ; Jorge Sanchez [Pérou] ; Breno Santos [Brésil] ; Khuanchai Supparatpinyo [Thaïlande] ; James Hakim [Zimbabwe] ; N. Kumarasamy [Inde] ; Thomas B. Campbell [États-Unis]Herpes Simplex Virus Type 2 Acquisition Among HIV-1-Infected Adults Treated With Tenofovir Disoproxyl Fumarate as Part of Combination Antiretroviral Therapy: Results From the ACTG A5175 PEARLS Study.
000313 Nnamdi O. Ndubuka [Afrique du Sud] ; Hyun J. Lim [Canada] ; Valerie J. Ehlers [Afrique du Sud] ; Dirk M. Van Der Wal [Afrique du Sud]Health-related quality of life of patients on antiretroviral treatment in Botswana: A cross-sectional study.
000322 Sergio Carmona [Afrique du Sud] ; Trevor Peter ; Leigh BerrieHIV viral load scale-up: multiple interventions to meet the HIV treatment cascade.
000345 Radha Rajasingham [États-Unis] ; Rachel M. Smith [États-Unis] ; Benjamin J. Park [États-Unis] ; Joseph N. Jarvis [Botswana] ; Nelesh P. Govender [Afrique du Sud] ; Tom M. Chiller [États-Unis] ; David W. Denning [Royaume-Uni] ; Angela Loyse [Royaume-Uni] ; David R. Boulware [États-Unis]Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis.
000347 Daniel F. Carr [Royaume-Uni] ; Stephane Bourgeois [Royaume-Uni] ; Mas Chaponda [Royaume-Uni] ; Louise Y. Takeshita [Royaume-Uni] ; Andrew P. Morris [Royaume-Uni] ; Elena M Cornejo Castro [Royaume-Uni] ; Ana Alfirevic [Royaume-Uni] ; Andrew R. Jones [Royaume-Uni] ; Daniel J. Rigden [Royaume-Uni] ; Sam Haldenby [Royaume-Uni] ; Saye Khoo [Royaume-Uni] ; David G. Lalloo [Royaume-Uni] ; Robert S. Heyderman [Malawi] ; Collet Dandara [Afrique du Sud] ; Elizabeth Kampira [Afrique du Sud] ; Joep J. Van Oosterhout [Malawi] ; Francis Ssali [Ouganda] ; Paula Munderi [Ouganda] ; Giuseppe Novelli [Italie] ; Paola Borgiani [Italie] ; Matthew R. Nelson [États-Unis] ; Arthur Holden [États-Unis] ; Panos Deloukas [Royaume-Uni] ; Munir Pirmohamed [Royaume-Uni]Genome-wide association study of nevirapine hypersensitivity in a sub-Saharan African HIV-infected population.
000354 Urvi M. Parikh [Afrique du Sud] ; Kevin Mccormick ; Gert Van Zyl ; John W. MellorsFuture technologies for monitoring HIV drug resistance and cure.
000357 Kerri J. Penrose [États-Unis] ; Carole L. Wallis [Afrique du Sud] ; Chanson J. Brumme [Canada] ; Kristen A. Hamanishi [États-Unis] ; Kelley C. Gordon [États-Unis] ; Raquel V. Viana [Afrique du Sud] ; P Richard Harrigan [Canada] ; John W. Mellors [États-Unis] ; Urvi M. Parikh [États-Unis]Frequent Cross-Resistance to Dapivirine in HIV-1 Subtype C-Infected Individuals after First-Line Antiretroviral Therapy Failure in South Africa.
000370 Ferdinand C. Mukumbang [Afrique du Sud] ; Sara Van Belle [Belgique] ; Bruno Marchal [Afrique du Sud] ; Brian Van Wyk [Afrique du Sud]Exploring 'generative mechanisms' of the antiretroviral adherence club intervention using the realist approach: a scoping review of research-based antiretroviral treatment adherence theories.
000388 Soter Ameh [Afrique du Sud, Nigeria] ; Kerstin Klipstein-Grobusch [Afrique du Sud, Pays-Bas] ; Eustasius Musenge [Afrique du Sud] ; Kathleen Kahn [Afrique du Sud, Ghana, Suède] ; Stephen Tollman [Afrique du Sud, Ghana, Suède] ; Francesc Xavier G Mez-Olivé [Afrique du Sud, Ghana]Effectiveness of an Integrated Approach to HIV and Hypertension Care in Rural South Africa: Controlled Interrupted Time-Series Analysis
000390 Jemma O'Connor [Royaume-Uni] ; Michael J. Vjecha [États-Unis] ; Andrew N. Phillips [Royaume-Uni] ; Brian Angus [Royaume-Uni] ; David Cooper [Australie] ; Beatriz Grinsztejn [Brésil] ; Gustavo Lopardo [Argentine] ; Satyajit Das [Royaume-Uni] ; Robin Wood [Afrique du Sud] ; Aimee Wilkin [États-Unis] ; Hartwig Klinker [Allemagne] ; Pacharee Kantipong [Thaïlande] ; Karin L. Klingman [États-Unis] ; David Jilich [République tchèque] ; Elbushra Herieka [Royaume-Uni] ; Eileen Denning [États-Unis] ; Ibrahim Abubakar [Royaume-Uni] ; Fred Gordin [États-Unis] ; Jens D. Lundgren [Danemark]Effect of immediate initiation of antiretroviral therapy on risk of severe bacterial infections in HIV-positive people with CD4 cell counts of more than 500 cells per μL: secondary outcome results from a randomised controlled trial.
000392 Ramla F. Tanko [Afrique du Sud] ; Andreia P. Soares [Afrique du Sud] ; Tracey L. Müller [Afrique du Sud] ; Nigel J. Garrett [Afrique du Sud] ; Natasha Samsunder [Afrique du Sud] ; Quarraisha Abdool Karim [Afrique du Sud] ; Salim S. Abdool Karim [Afrique du Sud] ; Catherine Riou [Afrique du Sud] ; Wendy A. Burgers [Afrique du Sud]Effect of Antiretroviral Therapy on the Memory and Activation Profiles of B Cells in HIV-Infected African Women.
000397 Francesca Celletti [Afrique du Sud] ; Gayle Sherman ; Ahmad H. MazanderaniEarly infant diagnosis of HIV: review of current and innovative practices.
000410 Willem Daniel Francois Venter [Afrique du Sud] ; Nathan Ford ; Marco Vitoria ; Wendy StevensDiagnosis and monitoring of HIV programmes to support treatment initiation and follow up and improve programme quality.
000415 Jill Hanass-Hancock [Afrique du Sud] ; Alison Misselhorn [Afrique du Sud] ; Bradley Carpenter [Afrique du Sud] ; Hellen Myezwa [Afrique du Sud]Determinants of livelihood in the era of widespread access to ART.
000425 Allison L. Agwu [États-Unis] ; Meredith G. Warshaw [États-Unis] ; Elizabeth J. Mcfarland [États-Unis] ; George K. Siberry [États-Unis] ; Ann J. Melvin [États-Unis] ; Andrew A. Wiznia [États-Unis] ; Lee Fairlie [Afrique du Sud] ; Sandra Boyd [États-Unis] ; Paul Harding [États-Unis] ; Hans M L. Spiegel [États-Unis] ; Elaine J. Abrams [États-Unis] ; Vincent J. Carey [États-Unis]Decline in CD4 T lymphocytes with monotherapy bridging strategy for non-adherent adolescents living with HIV infection: Results of the IMPAACT P1094 randomized trial.
000438 Rena C. Patel [États-Unis] ; Chelsea Morroni [Afrique du Sud] ; Kimberly K. Scarsi [États-Unis] ; Tabitha Sripipatana [États-Unis] ; James Kiarie [Suisse] ; Craig R. Cohen [États-Unis]Concomitant contraceptive implant and efavirenz use in women living with HIV: perspectives on current evidence and policy implications for family planning and HIV treatment guidelines.
000439 Erin Stern [Afrique du Sud] ; Christopher Colvin [Afrique du Sud] ; Nobom Gxabagxaba [Afrique du Sud] ; Charlotte Schutz [Afrique du Sud] ; Rosie Burton [Afrique du Sud] ; Graeme Meintjes [Afrique du Sud]Conceptions of agency and constraint for HIV-positive patients and healthcare workers to support long-term engagement with antiretroviral therapy care in Khayelitsha, South Africa.
000441 Cristin Q. Fritz [États-Unis] ; Meridith Blevins [États-Unis] ; Mary Lou Lindegren [États-Unis] ; Kara Wools-Kaloutsian [États-Unis] ; Beverly S. Musick [États-Unis] ; Morna Cornell [Afrique du Sud] ; Kelly Goodwin [Suisse] ; Dianne Addison [États-Unis] ; Jean Claude Dusingize [Rwanda] ; Eugène Messou [Côte d'Ivoire] ; Armel Poda [Burkina Faso] ; Stephany N. Duda [États-Unis] ; Catherine C. Mcgowan [États-Unis] ; Matthew G. Law [Australie] ; Richard D. Moore [États-Unis] ; Aimee Freeman [États-Unis] ; Denis Nash [États-Unis] ; C William Wester [États-Unis]Comprehensiveness of HIV care provided at global HIV treatment sites in the IeDEA consortium: 2009 and 2014.
000451 Sheree R. Schwartz [États-Unis] ; Jean Bassett [Afrique du Sud] ; Charles B. Holmes [Zambie] ; Nompumelelo Yende [Afrique du Sud] ; Rebecca Phofa [Afrique du Sud] ; Ian Sanne [Afrique du Sud] ; Annelies Van Rie [États-Unis]Client uptake of safer conception strategies: implementation outcomes from the Sakh'umndeni Safer Conception Clinic in South Africa.
000455 O. Bonnington [Royaume-Uni] ; J. Wamoyi ; W. Ddaaki [Ouganda] ; D. Bukenya [Ouganda] ; K. Ondenge [Kenya] ; M. Skovdal [Danemark] ; J. Renju [Royaume-Uni] ; M. Moshabela [Afrique du Sud] ; A. Wringe [Royaume-Uni]Changing forms of HIV-related stigma along the HIV care and treatment continuum in sub-Saharan Africa: a temporal analysis.
000456 Reneé De Waal [Afrique du Sud] ; Karen Cohen [Afrique du Sud] ; Matthew P. Fox [États-Unis] ; Kathryn Stinson [Afrique du Sud] ; Gary Maartens [Afrique du Sud] ; Andrew Boulle [Afrique du Sud] ; Ehimario U. Igumbor [Afrique du Sud] ; Mary-Ann Davies [Afrique du Sud]Changes in estimated glomerular filtration rate over time in South African HIV-1-infected patients receiving tenofovir: a retrospective cohort study.
000457 Georgina Spies [Afrique du Sud] ; Christine Fennema-Notestine [États-Unis] ; Mariana Cherner [États-Unis] ; Soraya Seedat [Afrique du Sud]Changes in cognitive function in women with HIV infection and early life stress.
000458 Eric Nagaonlé Somé [Norvège] ; Ingunn M S. Engebretsen [Norvège] ; Nicolas Nagot [France] ; Nicolas Y. Meda [Burkina Faso] ; Roselyne Vallo [France] ; Chipepo Kankasa [Zambie] ; James K. Tumwine [Ouganda] ; Mandisa Singata [Afrique du Sud] ; Justus G. Hofmeyr [Afrique du Sud] ; Philippe Van De Perre [France] ; Thorkild Tyllesk R [Norvège]Changes in body mass index and hemoglobin concentration in breastfeeding women living with HIV with a CD4 count over 350: Results from 4 African countries (The ANRS 12174 trial).
000459 Eliane Rohner [Suisse] ; Mazvita Sengayi [Afrique du Sud] ; Bridgette Goeieman [Afrique du Sud] ; Pamela Michelow [Afrique du Sud] ; Cynthia Firnhaber [Afrique du Sud] ; Mhairi Maskew [Afrique du Sud] ; Julia Bohlius [Suisse]Cervical cancer risk and impact of Pap-based screening in HIV-positive women on antiretroviral therapy in Johannesburg, South Africa.
000464 Hans Strijdom [Afrique du Sud] ; Patrick De Boever [Belgique] ; Gerhard Walzl [Afrique du Sud] ; M. Faadiel Essop [Afrique du Sud] ; Tim S. Nawrot [Belgique] ; Ingrid Webster [Afrique du Sud] ; Corli Westcott [Afrique du Sud] ; Nyiko Mashele [Afrique du Sud] ; Frans Everson [Afrique du Sud] ; Stephanus T. Malherbe [Afrique du Sud] ; Kim Stanley [Afrique du Sud] ; Harald H. Kessler [Autriche] ; Evelyn Stelzl [Autriche] ; Nandu Goswami [Autriche]Cardiovascular risk and endothelial function in people living with HIV/AIDS: design of the multi-site, longitudinal EndoAfrica study in the Western Cape Province of South Africa
000481 Mark A. Boyd [Australie] ; Janaki Amin [Australie] ; Patrick W G. Mallon [Irlande (pays)] ; Nagalingeswaran Kumarasamy [Inde] ; Johan Lombaard [Afrique du Sud] ; Robin Wood [Afrique du Sud] ; Ploenchan Chetchotisakd [Thaïlande] ; Praphan Phanuphak [Thaïlande] ; Lerato Mohapi [Afrique du Sud] ; Iskandar Azwa [Malaisie] ; Waldo H. Belloso [Argentine] ; Jean-Michel Molina [France] ; Jennifer Hoy [Australie] ; Cecilia L. Moore [Australie] ; Sean Emery [Australie] ; David A. Cooper [Australie]Body composition and metabolic outcomes after 96 weeks of treatment with ritonavir-boosted lopinavir plus either nucleoside or nucleotide reverse transcriptase inhibitors or raltegravir in patients with HIV with virological failure of a standard first-line antiretroviral therapy regimen: a substudy of the randomised, open-label, non-inferiority SECOND-LINE study.
000482 Theresa Rossouw [Afrique du Sud] ; Joseph D. Tucker [États-Unis] ; Gert U. Van Zyl [Afrique du Sud] ; Kenly Sikwesi [Zambie] ; Catherine Godfrey [États-Unis]Barriers to HIV remission research in low- and middle-income countries.
000488 Hannah M. Sebitloane [Afrique du Sud] ; Jagidesa Moodley [Afrique du Sud] ; Benn Sartorius [Afrique du Sud]Associations between HIV, highly active anti-retroviral therapy, and hypertensive disorders of pregnancy among maternal deaths in South Africa 2011-2013.
000489 Philip J. Palumbo [États-Unis] ; Ethan A. Wilson [États-Unis] ; Estelle Piwowar-Manning [États-Unis] ; Marybeth Mccauley [États-Unis] ; Theresa Gamble [États-Unis] ; Newton Kumwenda [Malawi] ; Joseph Makhema [Botswana] ; Nagalingeswaran Kumarasamy [Inde] ; Suwat Chariyalertsak [Thaïlande] ; James G. Hakim [Zimbabwe] ; Mina C. Hosseinipour [États-Unis] ; Marineide G. Melo [Brésil] ; Sheela V. Godbole [Inde] ; Jose H. Pilotto [Brésil] ; Beatriz Grinsztejn [Brésil] ; Ravindre Panchia [Afrique du Sud] ; Ying Q. Chen [États-Unis] ; Myron S. Cohen [États-Unis] ; Susan H. Eshleman [États-Unis] ; Jessica M. Fogel [États-Unis]Association of HIV diversity and virologic outcomes in early antiretroviral treatment: HPTN 052.
000497 Lindi Marie Coetzee [Afrique du Sud] ; Naseem Cassim ; Deborah Kim GlencrossAnalysis of HIV disease burden by calculating the percentages of patients with CD4 counts <100 cells/µL across 52 districts reveals hot spots for intensified commitment to programmatic support.
000508 Olalekan A. Uthman [Royaume-Uni] ; Olanrewaju Oladimeji [Afrique du Sud] ; Chidozie Nduka [Royaume-Uni]Adherence to antiretroviral therapy among HIV-infected prisoners: a systematic review and meta-analysis.
000522 Richard Hayes [Royaume-Uni] ; Sian Floyd [Royaume-Uni] ; Ab Schaap [Royaume-Uni] ; Kwame Shanaube [Zambie] ; Peter Bock [Afrique du Sud] ; Kalpana Sabapathy [Royaume-Uni] ; Sam Griffith [États-Unis] ; Deborah Donnell [États-Unis] ; Estelle Piwowar-Manning [États-Unis] ; Wafaa El-Sadr [États-Unis] ; Nulda Beyers [Afrique du Sud] ; Helen Ayles [Zambie] ; Sarah Fidler [Royaume-Uni]A universal testing and treatment intervention to improve HIV control: One-year results from intervention communities in Zambia in the HPTN 071 (PopART) cluster-randomised trial.
000539 Jenny Renju [Royaume-Uni] ; Mosa Moshabela [Afrique du Sud] ; Estelle Mclean [Royaume-Uni] ; William Ddaaki [Ouganda] ; Morten Skovdal [Danemark] ; Fred Odongo [Kenya] ; Dominic Bukenya [Ouganda] ; Joyce Wamoyi [Tanzanie] ; Oliver Bonnington [Royaume-Uni] ; Janet Seeley [Royaume-Uni] ; Basia Zaba [Royaume-Uni] ; Alison Wringe [Royaume-Uni]'Side effects' are 'central effects' that challenge retention in HIV treatment programmes in six sub-Saharan African countries: a multicountry qualitative study.
000542 Umberto Pellecchia [Malawi] ; Saar Baert [Afrique du Sud] ; Spencer Nundwe [Malawi] ; Andy Bwanali [Malawi] ; Bote Zamadenga [Malawi] ; Carol A. Metcalf [Afrique du Sud] ; Helen Bygrave [Afrique du Sud] ; Sarah Daho [Malawi] ; Liesbet Ohler [Malawi] ; Brown Chibwandira [Malawi] ; Kennedy Kanyimbo [Malawi]"We are part of a family". Benefits and limitations of community ART groups (CAGs) in Thyolo, Malawi: a qualitative study.
000547 Bronwyn Myers [Afrique du Sud] ; Katherine Sorsdahl [Afrique du Sud] ; Neo K. Morojele [Afrique du Sud] ; Connie Kekwaletswe [Afrique du Sud] ; Paul A. Shuper [Afrique du Sud] ; Charles D H. Parry [Afrique du Sud]"In this thing I have everything I need": perceived acceptability of a brief alcohol-focused intervention for people living with HIV.
000612 Jane Wathuta [Afrique du Sud]Gender inequality dynamics in the prevention of a heterosexual HIV epidemic in sub-Saharan Africa.
000616 Sylvie Boyer [France] ; Collins Iwuji [Afrique du Sud] ; Andréa Gosset [France] ; Camelia Protopopescu [France] ; Nonhlanhla Okesola [Afrique du Sud] ; Mélanie Plazy [France] ; Bruno Spire [France] ; Joanna Orne-Gliemann [France] ; Nuala Mcgrath [Afrique du Sud] ; Deenan Pillay [Afrique du Sud] ; François Dabis [France] ; Joseph Larmarange [Afrique du Sud]Factors associated with antiretroviral treatment initiation amongst HIV-positive individuals linked to care within a universal test and treat programme: early findings of the ANRS 12249 TasP trial in rural South Africa.
000621 Ute D. Feucht [Afrique du Sud] ; Anell Meyer [Afrique du Sud] ; Winifred N. Thomas [Afrique du Sud] ; Brian W C. Forsyth [Afrique du Sud] ; Mariana Kruger [Afrique du Sud]Early diagnosis is critical to ensure good outcomes in HIV-infected children: outlining barriers to care.
000629 Ingrid V. Bassett [États-Unis] ; Sharon M. Coleman [États-Unis] ; Janet Giddy [Afrique du Sud] ; Laura M. Bogart [États-Unis] ; Christine E. Chaisson [États-Unis] ; Douglas Ross [Afrique du Sud] ; Moses J. E. Flash [États-Unis] ; Tessa Govender [Afrique du Sud] ; Rochelle P. Walensky [États-Unis] ; Kenneth A. Freedberg [États-Unis] ; Elena Losina [États-Unis]Barriers to Care and 1-Year Mortality Among Newly Diagnosed HIV-Infected People in Durban, South Africa
000633 Kelsey B. Loeliger [États-Unis] ; Linda M. Niccolai [États-Unis] ; Lillian N. Mtungwa [Afrique du Sud] ; Anthony Moll [Afrique du Sud] ; Sheela V. Shenoi [États-Unis]Antiretroviral therapy initiation and adherence in rural South Africa: community health workers' perspectives on barriers and facilitators
000640 R. R. Lilian [Afrique du Sud] ; B. Mutasa [Afrique du Sud] ; J. Railton [Afrique du Sud] ; W. Mongwe [Afrique du Sud] ; J. A. Mcintyre [Afrique du Sud] ; H. E. Struthers [Afrique du Sud] ; R. P. H. Peters [Afrique du Sud]A 10-year cohort analysis of routine paediatric ART data in a rural South African setting
000659 Wilma A J. Norder [Pays-Bas] ; Remco P H. Peters [Afrique du Sud] ; Maarten O. Kok [Pays-Bas] ; Sabine L. Van Elsland [Pays-Bas] ; Helen E. Struthers [Afrique du Sud] ; Mpho A. Tutu [Afrique du Sud] ; A Marceline Van Furth [Pays-Bas]The church and paediatric HIV care in rural South Africa: a qualitative study.
000690 Selamawit Woldesenbet [Afrique du Sud] ; Debra Jackson [Afrique du Sud, États-Unis] ; Carl Lombard [Afrique du Sud] ; Thu-Ha Dinh [États-Unis] ; Adrian Puren [Afrique du Sud] ; Gayle Sherman [Afrique du Sud] ; Vundli Ramokolo [Afrique du Sud] ; Tanya Doherty [Afrique du Sud] ; Mary Mogashoa [Afrique du Sud] ; Sanjana Bhardwaj [Afrique du Sud] ; Mickey Chopra [Afrique du Sud, États-Unis] ; Nathan Shaffer [Suisse] ; Yogan Pillay [Afrique du Sud] ; Ameena Goga [Afrique du Sud]Missed Opportunities along the Prevention of Mother-to-Child Transmission Services Cascade in South Africa: Uptake, Determinants, and Attributable Risk (the SAPMTCTE)
000753 Irene Ketseoglou [Afrique du Sud] ; Azwidowi Lukhwareni ; Kim Steegen ; Sergio Carmona ; Wendy S. Stevens ; Maria A. PapathanasopoulosViral tropism and antiretroviral drug resistance in HIV-1 subtype C-infected patients failing highly active antiretroviral therapy in Johannesburg, South Africa.
000754 Barbara M. Heinze [Afrique du Sud] ; Bart M. Vinck [Belgique] ; Louis M. Hofmeyr [Afrique du Sud] ; De Wet Swanepoel [Australie]Vestibular involvement in adults with HIV/AIDS.
000755 Minrie Greeff [Afrique du Sud] ; Lignet M. Chepuka ; Winnie Chilemba ; Angela F. Chimwaza ; Lucy I. Kululanga ; Mabedi Kgositau ; Eva Manyedi ; Sheila Shaibu ; Susan C D. WrightUsing an innovative mixed method methodology to investigate the appropriateness of a quantitative instrument in an African context: Antiretroviral treatment and quality of life.
000763 Nicole Whitehead [Afrique du Sud] ; Joanne Potterton ; Ashraf CoovadiaThe neurodevelopment of HIV-infected infants on HAART compared to HIV-exposed but uninfected infants.
000798 Elysia Larson [Oman] ; Eran Bendavid [États-Unis] ; Maletela Tuoane-Nkhasi [Afrique du Sud] ; Thobile Mbengashe [Afrique du Sud] ; Thurma Goldman [Afrique du Sud] ; Melinda Wilson [États-Unis] ; Jeffrey D. Klausner [Afrique du Sud]Population-level associations between antiretroviral therapy scale-up and all-cause mortality in South Africa.
000799 Adegoke O. Adefolalu [Oman] ; Zerish Z. Nkosi [Afrique du Sud] ; Steve A S. Olorunju [Afrique du Sud]Patterns of adherence to scheduling and dietary instructions among patients on antiretroviral therapy in Pretoria, South Africa.
000800 Connie T. Kekwaletswe [Afrique du Sud] ; Neo K. MorojelePatterns and predictors of antiretroviral therapy use among alcohol drinkers at HIV clinics in Tshwane, South Africa.
000823 Geoffrey Fatti [Afrique du Sud] ; Najma Shaikh ; Brian Eley ; Ashraf GrimwoodImproved virological suppression in children on antiretroviral treatment receiving community-based adherence support: a multicentre cohort study from South Africa.
000830 R. Kader [Afrique du Sud] ; S. Seedat ; R. Govender ; J R Koch ; C D ParryHazardous and harmful use of alcohol and/or other drugs and health status among South African patients attending HIV clinics.
000833 Kathleen M S E. Reyskens [Afrique du Sud] ; M Faadiel Essop [Afrique du Sud]HIV protease inhibitors and onset of cardiovascular diseases: a central role for oxidative stress and dysregulation of the ubiquitin-proteasome system.
000845 Ashraf Kagee [Afrique du Sud] ; Adriaan Nel ; Wylene SaalFactor structure of the Beck Depression Inventory-II among South Africans receiving antiretroviral therapy.
000865 Anushka Naidoo [Afrique du Sud] ; Kogieleum Naidoo ; Nonhlanhla Yende-Zuma ; Tanuja N. Gengiah ; Nesri Padayatchi ; Andrew L. Gray ; Sheila Bamber ; Gonasagrie Nair ; Salim S Abdool KarimChanges to antiretroviral drug regimens during integrated TB-HIV treatment: results of the SAPiT trial.
000872 Max R. O Donnell [Afrique du Sud] ; Allison Wolf ; Lise Werner ; C Robert Horsburgh ; Nesri PadayatchiAdherence in the treatment of patients with extensively drug-resistant tuberculosis and HIV in South Africa: a prospective cohort study.
000873 Tanuja N. Gengiah [Afrique du Sud] ; Atika Moosa ; Anushka Naidoo ; Leila E. MansoorAdherence challenges with drugs for pre-exposure prophylaxis to prevent HIV infection.
000874 Samantha Black [Afrique du Sud] ; Rose Zulliger ; Rebecca Marcus ; Daniella Mark ; Landon Myer ; Linda-Gail BekkerAcceptability and challenges of rapid ART initiation among pregnant women in a pilot programme, Cape Town, South Africa.
000878 David J. Grelotti [États-Unis] ; Elizabeth F. Closson [États-Unis] ; Jennifer A. Smit [Afrique du Sud] ; Zonke Mabude [Afrique du Sud] ; Lynn T. Matthews [États-Unis] ; Steven A. Safren [États-Unis] ; David R. Bangsberg [États-Unis] ; Matthew J. Mimiaga [États-Unis]Whoonga: Potential recreational use of HIV antiretroviral medication in South Africa
000895 Gilles Wandeler [Afrique du Sud] ; Thomas Gsponer ; Lloyd Mulenga ; Daniela Garone ; Robin Wood ; Mhairi Maskew ; Hans Prozesky ; Christopher Hoffmann ; Jochen Ehmer ; Diana Dickinson ; Mary-Ann Davies ; Matthias Egger ; Olivia KeiserZidovudine impairs immunological recovery on first-line antiretroviral therapy: collaborative analysis of cohort studies in southern Africa.
000898 Michael Schomaker [Afrique du Sud] ; Matthias Egger ; James Ndirangu ; Sam Phiri ; Harry Moultrie ; Karl Technau ; Vivian Cox ; Janet Giddy ; Cleophas Chimbetete ; Robin Wood ; Thomas Gsponer ; Carolyn Bolton Moore ; Helena Rabie ; Brian Eley ; Lulu Muhe ; Martina Penazzato ; Shaffiq Essajee ; Olivia Keiser ; Mary-Ann DaviesWhen to start antiretroviral therapy in children aged 2-5 years: a collaborative causal modelling analysis of cohort studies from southern Africa.
000899 Kogieleum Naidoo [Afrique du Sud] ; Cheryl Baxter ; Salim S. Abdool KarimWhen to start antiretroviral therapy during tuberculosis treatment?
000908 Mhairi Maskew [Afrique du Sud] ; Matthew P. Fox ; Gilles Van Cutsem ; Kathryn Chu ; Patrick Macphail ; Andrew Boulle ; Matthias Egger ; For Iedea Southern AfricaTreatment response and mortality among patients starting antiretroviral therapy with and without Kaposi sarcoma: a cohort study.
000917 Adriaan Nel [Afrique du Sud] ; Ashraf KageeThe relationship between depression, anxiety and medication adherence among patients receiving antiretroviral treatment in South Africa.
000930 Quarraisha Abdool Karim [Afrique du Sud]The global HIV epidemic: current status and challenges.
000933 Bronwyne Coetzee [Afrique du Sud] ; Ashraf KageeThe development of an inventory to assess the structural barriers to clinic attendance and pill-taking amongst users of antiretroviral therapy.
000937 June Fabian [Afrique du Sud] ; Saraladevi Naicker ; Stewart Goetsch ; Willem Daniel Francois VenterThe clinical and histological response of HIV-associated kidney disease to antiretroviral therapy in South Africans.
000942 Ankur Gupta-Wright [Afrique du Sud] ; Robin Wood ; Linda-Gail Bekker ; Stephen D. LawnTemporal association between incident tuberculosis and poor virological outcomes in a South African antiretroviral treatment service.
000945 Karl Peltzer [Afrique du Sud] ; Supa Pengpid [Afrique du Sud]Socioeconomic Factors in Adherence to HIV Therapy in Low- and Middle-income Countries
000950 Jean Pierre Kabue [Afrique du Sud] ; Dalene De Swardt ; Corena De Beer ; Richard H. GlashoffShort-term antiretroviral therapy fails to reduce the expanded activated CCR5-expressing CD4+ T lymphocyte population or to restore the depleted naive population in chronically HIV-infected individuals with active pulmonary tuberculosis.
000981 Adegoke O. Adefolalu [Afrique du Sud]Prevalence of HIV infection among survivors of sexual assault at presentation in hospital.
000989 Werner Smidt [Afrique du Sud]Potential elucidation of a novel CTL epitope in HIV-1 protease by the protease inhibitor resistance mutation L90M.
000995 Ingrid M. Le Roux [Afrique du Sud] ; Mark Tomlinson ; Jessica M. Harwood ; Mary J. O'Connor ; Carol M. Worthman ; Nokwanele Mbewu ; Jacqueline Stewart ; Mary Hartley ; Dallas Swendeman ; W Scott Comulada ; Robert E. Weiss ; Mary Jane Rotheram-BorusOutcomes of home visits for pregnant mothers and their infants: a cluster randomized controlled trial.
000997 Prinitha Pillay [Afrique du Sud] ; Nathan Ford ; Zara Shubber ; Rashida A. FerrandOutcomes for efavirenz versus nevirapine-containing regimens for treatment of HIV-1 infection: a systematic review and meta-analysis.
000998 Cari Van Schalkwyk [Afrique du Sud] ; Sibongile Mndzebele ; Thabo Hlophe ; Jesus Maria Garcia Calleja ; Eline L. Korenromp ; Rand Stoneburner ; Cyril PervilhacOutcomes and impact of HIV prevention, ART and TB programs in Swaziland--early evidence from public health triangulation.
000999 André R S. Périssé [Brésil] ; Laura Smeaton [États-Unis] ; Yun Chen [États-Unis] ; Alberto La Rosa [Pérou] ; Ann Walawander [États-Unis] ; Apsara Nair [États-Unis] ; Beatriz Grinsztejn [Brésil] ; Breno Santos [Brésil] ; Cecilia Kanyama [Malawi] ; James Hakim [Zimbabwe] ; Mulinda Nyirenda [Malawi] ; Nagalingeswaran Kumarasamy [Inde] ; Umesh G. Lalloo [Afrique du Sud] ; Timothy Flanigan [États-Unis] ; Thomas B. Campbell [États-Unis] ; Michael D. Hughes [États-Unis]Outcomes among HIV-1 infected individuals first starting antiretroviral therapy with concurrent active TB or other AIDS-defining disease.
000A03 Mgaywa Gilbert Mjungu Damas Magafu [Botswana] ; Kazuhiko Moji [Japon] ; Ehimario Uche Igumbor [Afrique du Sud] ; Naoko Shimizu Magafu [Tanzanie] ; Michael Mwandri [Botswana] ; Julius Chacha Mwita [Botswana] ; Dereje Habte [Botswana] ; Godfrey Mutashambara Rwegerera [Botswana] ; Masahiro Hashizume [Japon]Non-communicable diseases in antiretroviral therapy recipients in Kagera Tanzania: a cross-sectional study.
000A05 Kavita Nanda [Afrique du Sud] ; Sinead Delany-Moretlwe ; Karine Dubé ; Anja Lendvay ; Cynthia Kwok ; Lebohang Molife ; Sarah Nakubulwa ; Vinodh A. Edward ; Bernard Mpairwe ; Florence M. MirembeNevirapine-based antiretroviral therapy does not reduce oral contraceptive effectiveness.
000A06 Barbara Laughton [Afrique du Sud] ; Morna Cornell ; Michael Boivin ; Annelies Van RieNeurodevelopment in perinatally HIV-infected children: a concern for adolescence.
000A14 Elizabeth Kampira [Afrique du Sud] ; Johnstone Kumwenda ; Joep J. Van Oosterhout ; Collet DandaraMitochondrial subhaplogroups and differential risk of stavudine-induced lipodystrophy in Malawian HIV/AIDS patients.
000A15 Phumla Z. Sinxadi [Afrique du Sud] ; Joel A. Dave ; David C. Samuels ; Jeannine M. Heckmann ; Gary Maartens ; Naomi S. Levitt ; C William Wester ; David W. Haas ; Todd HulganMitochondrial genomics and antiretroviral therapy-associated metabolic complications in HIV-infected Black South Africans: a pilot study.
000A18 Lungile J. Sitole [Afrique du Sud] ; Aurelia A. Williams ; Debra MeyerMetabonomic analysis of HIV-infected biofluids.
000A23 Ruth M. Bland [Afrique du Sud] ; James Ndirangu ; Marie-Louise NewellMaximising opportunities for increased antiretroviral treatment in children in an existing HIV programme in rural South Africa.
000A25 Chris Bateman [Afrique du Sud]MSF again paves the way with ART.
000A26 Landon Myer [Afrique du Sud] ; Monika Kamkuemah ; Richard Kaplan ; Linda-Gail BekkerLow prevalence of renal dysfunction in HIV-infected pregnant women: implications for guidelines for the prevention of mother-to-child transmission of HIV.
000A29 Nei-Yuan Hsiao [Afrique du Sud] ; Kathryn Stinson ; Landon MyerLinkage of HIV-infected infants from diagnosis to antiretroviral therapy services across the Western Cape, South Africa.
000A30 Leigh F. Johnson [Afrique du Sud] ; Joel Mossong [Afrique du Sud] ; Rob E. Dorrington [Afrique du Sud] ; Michael Schomaker [Afrique du Sud] ; Christopher J. Hoffmann [Afrique du Sud, États-Unis] ; Olivia Keiser [Suisse] ; Matthew P. Fox [États-Unis, Afrique du Sud] ; Robin Wood [Afrique du Sud] ; Hans Prozesky [Afrique du Sud] ; Janet Giddy [Afrique du Sud] ; Daniela Belen Garone [Afrique du Sud] ; Morna Cornell [Afrique du Sud] ; Matthias Egger [Suisse] ; Andrew Boulle [Afrique du Sud]Life Expectancies of South African Adults Starting Antiretroviral Treatment: Collaborative Analysis of Cohort Studies
000A32 Sugeshnee Pather [Afrique du Sud] ; Zainab Mohamed ; Heather Mcleod ; Komala PillayLarge cell lymphoma: correlation of HIV status and prognosis with differentiation profiles assessed by immunophenotyping.
000A43 Thu-Ha Dinh [Afrique du Sud] ; Mary L. Kamb ; Veerle Msimang ; Muptal Likibi ; Thabo Molebatsi ; Thurma Goldman ; David A. LewisIntegration of preventing mother-to-child transmission of HIV and syphilis testing and treatment in antenatal care services in the Northern Cape and Gauteng provinces, South Africa.
000A46 Kate Clouse [Afrique du Sud] ; Audrey Pettifor ; Mhairi Maskew ; Jean Bassett ; Annelies Van Rie ; Cynthia Gay ; Frieda Behets ; Ian Sanne ; Matthew P. FoxInitiating antiretroviral therapy when presenting with higher CD4 cell counts results in reduced loss to follow-up in a resource-limited setting.
000A50 Gabriela E M. Patten [Afrique du Sud] ; Lynne Wilkinson ; Karien Conradie ; Petros Isaakidis ; Anthony D. Harries ; Mary E. Edginton ; Virginia De Azevedo ; Gilles Van CutsemImpact on ART initiation of point-of-care CD4 testing at HIV diagnosis among HIV-positive youth in Khayelitsha, South Africa.
000A54 Michael Schomaker [Afrique du Sud] ; Matthias Egger ; Mhairi Maskew ; Daniela Garone ; Hans Prozesky ; Christopher J. Hoffmann ; Andrew Boulle ; Lukas FennerImmune recovery after starting ART in HIV-infected patients presenting and not presenting with tuberculosis in South Africa.
000A62 Marelize Swart [Afrique du Sud] ; Michelle Skelton ; Yuan Ren ; Peter Smith ; Simbabrashe Takuva ; Collet DandaraHigh predictive value of CYP2B6 SNPs for steady-state plasma efavirenz levels in South African HIV/AIDS patients.
000A63 Heidi Van Rooyen [Afrique du Sud] ; Ruanne V. Barnabas ; Jared M. Baeten ; Zipho Phakathi ; Philip Joseph ; Meighan Krows ; Ting Hong ; Pamela M. Murnane ; James Hughes ; Connie CelumHigh HIV testing uptake and linkage to care in a novel program of home-based HIV counseling and testing with facilitated referral in KwaZulu-Natal, South Africa.
000A66 Jeffrey W. Eaton [Royaume-Uni] ; Nicolas A. Menzies [États-Unis] ; John Stover [États-Unis] ; Valentina Cambiano [Royaume-Uni] ; Leonid Chindelevitch [États-Unis] ; Anne Cori [Royaume-Uni] ; Jan A C. Hontelez [Pays-Bas] ; Salal Humair [États-Unis] ; Cliff C. Kerr [Australie] ; Daniel J. Klein [États-Unis] ; Sharmistha Mishra [Canada] ; Kate M. Mitchell [Royaume-Uni] ; Brooke E. Nichols [Pays-Bas] ; Peter Vickerman [Royaume-Uni] ; Roel Bakker [Pays-Bas] ; Till B Rnighausen [États-Unis] ; Anna Bershteyn [États-Unis] ; David E. Bloom [États-Unis] ; Marie-Claude Boily [Royaume-Uni] ; Stewart T. Chang [États-Unis] ; Ted Cohen [États-Unis] ; Peter J. Dodd [Royaume-Uni] ; Christophe Fraser [Royaume-Uni] ; Chaitra Gopalappa [États-Unis] ; Jens Lundgren [Danemark] ; Natasha K. Martin [Royaume-Uni] ; Evelinn Mikkelsen [Pays-Bas] ; Elisa Mountain [Royaume-Uni] ; Quang D. Pham [Australie] ; Michael Pickles [Royaume-Uni] ; Andrew Phillips [Royaume-Uni] ; Lucy Platt [Royaume-Uni] ; Carel Pretorius [États-Unis] ; Holly J. Prudden [Royaume-Uni] ; Joshua A. Salomon [États-Unis] ; David A M C. Van De Vijver [Pays-Bas] ; Sake J. De Vlas [Pays-Bas] ; Bradley G. Wagner [États-Unis] ; Richard G. White [Royaume-Uni] ; David P. Wilson [Australie] ; Lei Zhang [Australie] ; John Blandford [États-Unis] ; Gesine Meyer-Rath [Afrique du Sud] ; Michelle Remme [Royaume-Uni] ; Paul Revill [Royaume-Uni] ; Nalinee Sangrujee [États-Unis] ; Fern Terris-Prestholt [Royaume-Uni] ; Meg Doherty [Suisse] ; Nathan Shaffer [Suisse] ; Philippa J. Easterbrook [Suisse] ; Gottfried Hirnschall [Suisse] ; Timothy B. Hallett [Royaume-Uni]Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models.
000A70 Karl Peltzer [Afrique du Sud, Thaïlande]HIV-related symptoms and management in HIV and antiretroviral therapy patients in KwaZulu-Natal, South Africa: A longitudinal study
000A83 Anil Bhagwanjee [Afrique du Sud] ; Kaymarlin Govender ; Candice Reardon ; Leigh Johnstone ; Gavin George ; Sarah GordonGendered constructions of the impact of HIV and AIDS in the context of the HIV-positive seroconcordant heterosexual relationship.
000A84 Megan Palmer [Afrique du Sud] ; Matthew Chersich ; Harry Moultrie ; Louise Kuhn ; Lee Fairlie ; Tammy MeyersFrequency of stavudine substitution due to toxicity in children receiving antiretroviral treatment in sub-Saharan Africa.
000A88 Mike Sathekge [Afrique du Sud] ; Alex Maes ; Christophe Van De WieleFDG-PET imaging in HIV infection and tuberculosis.
000A90 Gavin George [Afrique du Sud] ; Ethel Chitindingu ; Jeff GowEvaluating traditional healers knowledge and practices related to HIV testing and treatment in South Africa.
000A97 Omphile E. Simani [Afrique du Sud] ; Peter V. Adrian ; Avy Violari ; Locadiah Kuwanda ; Kennedy Otwombe ; Marta C. Nunes ; Mark F. Cotton ; Shabir A. MadhiEffect of in-utero HIV exposure and antiretroviral treatment strategies on measles susceptibility and immunogenicity of measles vaccine.
000A99 Julia H. Goedecke [Afrique du Sud] ; Lisa K. Micklesfield ; Naomi S. Levitt ; Estelle V. Lambert ; Sacha West ; Gary Maartens ; Joel A. DaveEffect of different antiretroviral drug regimens on body fat distribution of HIV-infected South African women.
000B03 Jaffer Zaidi [Afrique du Sud] ; Erofili Grapsa [Afrique du Sud] ; Frank Tanser [Afrique du Sud] ; Marie-Louise Newell [Afrique du Sud, États-Unis] ; Till B Rnighausen [Afrique du Sud, Royaume-Uni]Dramatic increases in HIV prevalence after scale-up of antiretroviral treatment: a longitudinal population-based HIV surveillance study in rural kwazulu-natal
000B06 S D Lawn [Afrique du Sud] ; A D Kerkhoff ; M. Vogt ; R. WoodDiagnostic and prognostic value of serum C-reactive protein for screening for HIV-associated tuberculosis.
000B22 Peter Bock [Afrique du Sud] ; Geoffrey Fatti ; Ashraf GrimwoodComparing the effectiveness of efavirenz and nevirapine for first-line antiretroviral therapy in a South African multicentre cohort.
000B27 Muki S. Shey [Afrique du Sud] ; Eugene J. Kongnyuy ; Samuel M. Alobwede ; Charles Shey WiysongeCo-formulated abacavir-lamivudine-zidovudine for initial treatment of HIV infection and AIDS.
000B37 Kathleen M S E. Reyskens [Afrique du Sud] ; Tarryn-Lee Fisher ; Jonathan C. Schisler ; Wendi G. O'Connor ; Arlin B. Rogers ; Monte S. Willis ; Cynthia Planesse ; Florence Boyer ; Philippe Rondeau ; Emmanuel Bourdon ; M Faadiel EssopCardio-metabolic effectsof HIV protease inhibitors (lopinavir/ritonavir).
000B49 Jerome Amir Singh [Afrique du Sud]Antiretroviral resource allocation for HIV prevention.
000B58 Sophia Pathai [Royaume-Uni, Afrique du Sud] ; Stephen D. Lawn [Afrique du Sud, Royaume-Uni] ; Clare E. Gilbert [Royaume-Uni] ; Dagmara Mcguinness [Royaume-Uni] ; Liane Mcglynn [Royaume-Uni] ; Helen A. Weiss [Royaume-Uni] ; Jennifer Port [Royaume-Uni] ; Theresa Christ [Royaume-Uni] ; Karen Barclay [Royaume-Uni] ; Robin Wood [Afrique du Sud] ; Linda-Gail Bekker [Afrique du Sud] ; Paul G. Shiels [Royaume-Uni]Accelerated biological ageing in HIV-infected individuals in South Africa: a case–control study
000B72 S. Dewing [Afrique du Sud] ; C. Mathews ; N. Schaay ; A. Cloete ; J. Louw ; L. Simbayi"It's important to take your medication everyday okay?" An evaluation of counselling by lay counsellors for ARV adherence support in the Western Cape, South Africa.
000C39 Charles R. Swanepoel [Afrique du Sud] ; Nicola Wearne ; Maureen S. Duffield ; Ikechi G. OkpechiThe evolution of our knowledge of HIV-associated kidney disease in Africa.
000C42 Sphiwe Madiba [Afrique du Sud]The Impact of Fear, Secrecy, and Stigma on Parental Disclosure of HIV Status to Children: A Qualitative Exploration with HIV Positive Parents Attending an ART Clinic in South Africa
000C51 Erica Breuer [Afrique du Sud] ; Kevin Stoloff ; Landon Myer ; Soraya Seedat ; Dan J. Stein ; John JoskaReliability of the lay adherence counsellor administered substance abuse and mental illness symptoms screener (SAMISS) and the International HIV Dementia Scale (IHDS) in a primary care HIV clinic in Cape Town, South Africa.
000C57 Jacob Bor [États-Unis, Afrique du Sud] ; Frank Tanser [Afrique du Sud] ; Marie-Louise Newell [Afrique du Sud, Royaume-Uni] ; Till B Rnighausen [États-Unis, Afrique du Sud]Nearly Full Employment Recovery Among South African HIV Patients On Antiretroviral Therapy: Evidence From A Large Population Cohort
000C72 Sheree R. Schwartz [Afrique du Sud] ; Shruti H. Mehta ; Taha E. Taha ; Helen V. Rees ; Francois Venter ; Vivian BlackHigh pregnancy intentions and missed opportunities for patient-provider communication about fertility in a South African cohort of HIV-positive women on antiretroviral therapy.
000C77 Ikuma Nozaki [Zambie, États-Unis] ; Mika Kuriyama [Zambie, Autriche] ; Pauline Manyepa [Zambie] ; Matilda K. Zyambo [Zambie] ; Kazuhiro Kakimoto [Japon] ; Till B Rnighausen [États-Unis, Afrique du Sud]False Beliefs About ART Effectiveness, Side Effects and the Consequences of Non-retention and Non-adherence Among ART Patients in Livingstone, Zambia
000D58 Claire Penn [Afrique du Sud] ; Jennifer Watermeyer ; Melanie EvansWhy don't patients take their drugs? The role of communication, context and culture in patient adherence and the work of the pharmacist in HIV/AIDS.
000D63 Karl Peltzer [Afrique du Sud] ; Shandir Ramlagan ; Mohamed Salim Khan ; Bernhard GaedeThe social and clinical characteristics of patients on antiretroviral therapy who are 'lost to follow-up' in KwaZulu-Natal, South Africa: a prospective study.
000D69 Bronwyne Coetzee [Afrique du Sud] ; Ashraf Kagee ; Nadia VermeulenStructural barriers to adherence to antiretroviral therapy in a resource-constrained setting: the perspectives of health care providers.
000D78 Karl Peltzer [Afrique du Sud] ; Shandir RamlaganPerceived stigma among patients receiving antiretroviral therapy: a prospective study in KwaZulu-Natal, South Africa.
000D90 H. Myezwa [Afrique du Sud] ; C M Buchalla ; J. Jelsma ; A. StewartHIV/AIDS: use of the ICF in Brazil and South Africa--comparative data from four cross-sectional studies.
000D94 Antonia L. Wadley [Afrique du Sud] ; Catherine L. Cherry ; Patricia Price ; Peter R. KamermanHIV neuropathy risk factors and symptom characterization in stavudine-exposed South Africans.
000E05 Dikokole Maqutu [Afrique du Sud] ; Temesgen Zewotir [Afrique du Sud] ; Delia North [Afrique du Sud] ; Kogieleum Naidoo [Afrique du Sud] ; Anneke Grobler [Afrique du Sud]Determinants of optimal adherence over time to antiretroviral therapy amongst HIV positive adults in South Africa: A longitudinal study
000E12 Susan M. Cleary [Afrique du Sud] ; Gavin H. Mooney ; Diane E. McintyreClaims on health care: a decision-making framework for equity, with application to treatment for HIV/AIDS in South Africa.
000E13 S. Mepham [Afrique du Sud] ; Z. Zondi ; A. Mbuyazi ; N. Mkhwanazi ; M L NewellChallenges in PMTCT antiretroviral adherence in northern KwaZulu-Natal, South Africa.
000E58 D. Cristina Stefan [Afrique du Sud] ; David K. Stones [Afrique du Sud] ; Linda Wainwright [Afrique du Sud] ; Robert Newton [Royaume-Uni]Kaposi sarcoma in South African children
000E83 Ziad El-Khatib [Suède, Afrique du Sud] ; Anna Mia Ekström [Suède] ; Johanna Ledwaba [Afrique du Sud] ; Lerato Mohapi [Afrique du Sud] ; Fatima Laher [Afrique du Sud] ; Alan Karstaedt [Afrique du Sud] ; Salome Charalambous [Afrique du Sud] ; Max Petzold [Suède] ; David Katzenstein [États-Unis] ; Lynn Morris [Afrique du Sud]nViremia and drug resistance among HIV-1 patients on antiretroviral treatment – a cross-sectional study in Soweto, South Africa
000E86 Anna Coutsoudis [Afrique du Sud] ; Kirsty England ; Nigel Rollins ; Hoosen Coovadia ; Marie-Louise Newell ; Ruth BlandWomen's morbidity and mortality in the first 2 years after delivery according to HIV status.
000E95 Stephanus Komati [Afrique du Sud] ; Pamela A. Shaw ; Nomso Stubbs ; Monkwe J. Mathibedi ; Lizette Malan ; Phumelele Sangweni ; Julia A. Metcalf ; Henry Masur ; Shaheen HassimTuberculosis risk factors and mortality for HIV-infected persons receiving antiretroviral therapy in South Africa.
000E96 Stephen D. Lawn [Afrique du Sud] ; Katharina Kranzer ; David J. Edwards ; Matthew Mcnally ; Linda-Gail Bekker ; Robin WoodTuberculosis during the first year of antiretroviral therapy in a South African cohort using an intensive pretreatment screening strategy.
000E98 Salim S. Abdool Karim [Afrique du Sud] ; Kogieleum Naidoo ; Anneke Grobler ; Nesri Padayatchi ; Cheryl Baxter ; Andrew Gray ; Tanuja Gengiah ; Gonasagrie Nair ; Sheila Bamber ; Aarthi Singh ; Munira Khan ; Jacqueline Pienaar ; Wafaa El-Sadr ; Gerald Friedland ; Quarraisha Abdool KarimTiming of initiation of antiretroviral drugs during tuberculosis therapy.
000F04 Gita Ramjee [Afrique du Sud] ; Anatoli Kamali ; Sheena MccormackThe last decade of microbicide clinical trials in Africa: from hypothesis to facts.
000F06 Lawrence Long [Afrique du Sud] ; Matthew Fox ; Ian Sanne ; Sydney RosenThe high cost of second-line antiretroviral therapy for HIV/AIDS in South Africa.
000F10 Craig G. Arendse [Afrique du Sud] ; Nicola Wearne ; Ikechi G. Okpechi ; Charles R. SwanepoelThe acute, the chronic and the news of HIV-related renal disease in Africa.
000F11 Quarraisha Abdool Karim [Afrique du Sud] ; Salim S. Abdool Karim ; Cheryl Baxter ; Gerald Friedland ; Tanuja Gengiah ; Andrew Gray ; Anneke Grobler ; Kogileum Naidoo ; Nesri Padayatchi ; Wafaa El-SadrThe SAPIT trial provides essential evidence on risks and benefits of integrated and sequential treatment of HIV and tuberculosis.
000F12 Morna Cornell [Afrique du Sud] ; Anna Grimsrud ; Lara Fairall ; Matthew P. Fox ; Gilles Van Cutsem ; Janet Giddy ; Robin Wood ; Hans Prozesky ; Lerato Mohapi ; Claire Graber ; Matthias Egger ; Andrew Boulle ; Landon MyerTemporal changes in programme outcomes among adult patients initiating antiretroviral therapy across South Africa, 2002-2007.
000F15 Gavin J. Churchyard [Afrique du Sud] ; Katherine L. Fielding ; James J. Lewis ; Violet N. Chihota ; Yasmeen Hanifa ; Alison D. GrantSymptom and chest radiographic screening for infectious tuberculosis prior to starting isoniazid preventive therapy: yield and proportion missed at screening.
000F19 Stephen D. Lawn [Afrique du Sud] ; Anthony D. Harries ; Robin WoodStrategies to reduce early morbidity and mortality in adults receiving antiretroviral therapy in resource-limited settings.
000F21 Brendan Maughan-Brown [Afrique du Sud]Stigma rises despite antiretroviral roll-out: a longitudinal analysis in South Africa.
000F37 Karl Peltzer [Afrique du Sud] ; Shandir RamlaganSafer sexual behaviours after 1 year of antiretroviral treatment in KwaZulu-Natal, South Africa: a prospective cohort study.
000F41 Christopher J. Hoffmann [Afrique du Sud] ; Katherine L. Fielding ; Salome Charalambous ; Craig Innes ; Richard E. Chaisson ; Alison D. Grant ; Gavin J. ChurchyardReducing mortality with cotrimoxazole preventive therapy at initiation of antiretroviral therapy in South Africa.
000F50 R J Li [Afrique du Sud] ; H B Jaspan ; V. O'Brien ; H. Rabie ; M F Cotton ; N. NattrassPositive futures: a qualitative study on the needs of adolescents on antiretroviral therapy in South Africa.
000F57 Edana Cassol [Afrique du Sud] ; Susan Malfeld ; Phetole Mahasha ; Schalk Van Der Merwe ; Sharon Cassol ; Chris Seebregts ; Massimo Alfano ; Guido Poli ; Theresa RossouwPersistent microbial translocation and immune activation in HIV-1-infected South Africans receiving combination antiretroviral therapy.
000F64 Helena Rabie [Afrique du Sud] ; Andrea Lomp ; Pierre Goussard ; Ettienne Nel ; Mark CottonParadoxical tuberculosis associated immune reconstitution inflammatory syndrome presenting with chylous ascites and chylothorax in a HIV-1 infected child.
000F67 Jerome Amir Singh [Afrique du Sud]Organ transplantation between HIV-infected patients.
000F73 Muhammad Q. Fish [Afrique du Sud] ; Raymond Hewer ; Carole L. Wallis ; Willem D F. Venter ; Wendy S. Stevens ; Maria A. PapathanasopoulosNatural polymorphisms of integrase among HIV type 1-infected South African patients.
000F75 Lisa C. Du Toit [Afrique du Sud] ; Viness Pillay ; Yahya E. ChoonaraNano-microbicides: challenges in drug delivery, patient ethics and intellectual property in the war against HIV/AIDS.
000F81 Karen Cohen [Afrique du Sud] ; Graeme MeintjesManagement of individuals requiring antiretroviral therapy and TB treatment.
000F83 Diane Gray [Afrique du Sud] ; James Nuttall ; Carl Lombard ; Mary-Ann Davies ; Lesley Workman ; Patti Apolles ; Brian Eley ; Mark Cotton ; Heather J. Zar ; Heather ZarLow rates of hepatotoxicity in HIV-infected children on anti-retroviral therapy with and without isoniazid prophylaxis.
000F94 Geoffrey Fatti [Afrique du Sud] ; Peter Bock ; Ashraf Grimwood ; Brian EleyIncreased vulnerability of rural children on antiretroviral therapy attending public health facilities in South Africa: a retrospective cohort study.
001007 B L Meel [Afrique du Sud]HIV/AIDS and traditional healers: a blessing in disguise.
001011 Pascaline N. Fonteh [Afrique du Sud] ; Frankline K. Keter ; Debra MeyerHIV therapeutic possibilities of gold compounds.
001021 Niel Malan [Afrique du Sud] ; Jun Su ; Marco Mancini ; Rong Yang ; Victoria Wirtz ; Judith Absalon ; Donnie McgrathGastrointestinal tolerability and quality of life in antiretroviral-naive HIV-1-infected patients: data from the CASTLE study.
001034 Tamaryn Crankshaw [Afrique du Sud] ; Inge B. Corless ; Janet Giddy ; Patrice K. Nicholas ; Quentin Eichbaum ; Lisa M. ButlerExploring the patterns of use and the feasibility of using cellular phones for clinic appointment reminders and adherence messages in an antiretroviral treatment clinic, Durban, South Africa.
001042 Susan Cleary [Afrique du Sud]Equity and efficiency in scaling up access to HIV-related interventions in resource-limited settings.
001046 Shabir A. Madhi [Afrique du Sud] ; Peter Adrian ; Mark F. Cotton ; James A. Mcintyre ; Patrick Jean-Philippe ; Shawn Meadows ; Sharon Nachman ; Helena K Yhty ; Keith P. Klugman ; Avye ViolariEffect of HIV infection status and anti-retroviral treatment on quantitative and qualitative antibody responses to pneumococcal conjugate vaccine in infants.
001047 Michelle Viljoen [Afrique du Sud] ; Hermien Gous ; Herculina S. Kruger ; Alison Riddick ; Tammy M. Meyers ; Malie RheedersEfavirenz plasma concentrations at 1, 3, and 6 months post-antiretroviral therapy initiation in HIV type 1-infected South African children.
001048 Sydney Rosen [États-Unis, Afrique du Sud] ; Bruce Larson [États-Unis] ; Alana Brennan [États-Unis, Afrique du Sud] ; Lawrence Long [Afrique du Sud] ; Matthew Fox [États-Unis, Afrique du Sud] ; Constance Mongwenyana [Afrique du Sud] ; Mpefe Ketlhapile [Afrique du Sud] ; Ian Sanne [Afrique du Sud]Economic Outcomes of Patients Receiving Antiretroviral Therapy for HIV/AIDS in South Africa Are Sustained through Three Years on Treatment
001049 Keertan Dheda [Afrique du Sud] ; Karen Shean ; Alimuddin Zumla ; Motasim Badri ; Elizabeth M. Streicher ; Liesl Page-Shipp ; Paul Willcox ; Melanie-Anne John ; Gary Reubenson ; Darshini Govindasamy ; Michelle Wong ; Xavier Padanilam ; Alicia Dziwiecki ; Paul D. Van Helden ; Sweetness Siwendu ; Julie Jarand ; Colin N. Menezes ; Avril Burns ; Thomas Victor ; Robin Warren ; Martin P. Grobusch ; Martie Van Der Walt ; Charlotte KvasnovskyEarly treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study.
001055 Kartik K. Venkatesh [États-Unis] ; Guy De Bruyn [Afrique du Sud] ; Mark N. Lurie [États-Unis] ; Lerato Mohapi [Afrique du Sud] ; Paul Pronyk [États-Unis] ; Mosa Moshabela [Afrique du Sud] ; Edmore Marinda [Afrique du Sud] ; Glenda E. Gray [Afrique du Sud] ; Elizabeth W. Triche [États-Unis] ; Neil A. Martinson [Afrique du Sud, États-Unis]Decreased sexual risk behavior in the era of HAART among HIV-infected urban and rural South Africans attending primary care clinics
001056 James Ndirangu [Afrique du Sud] ; Marie-Louise Newell [Afrique du Sud] ; Frank Tanser [Afrique du Sud] ; Abraham J. Herbst [Afrique du Sud] ; Ruth Bland [Afrique du Sud, Royaume-Uni]Decline in early life mortality in a high HIV prevalence rural area of South Africa: evidence of HIV prevention or treatment impact?
001065 C. Schutz [Afrique du Sud] ; G. Meintjes ; F. Almajid ; R J Wilkinson ; A. PozniakClinical management of tuberculosis and HIV-1 co-infection.
001088 Ebrahim Bera [Afrique du Sud] ; Katrin Mccausland ; Roxaan Nonkwelo ; Batembu Mgudlwa ; Saji Chacko ; Busiwe MajekeBirth defects following exposure to efavirenz-based antiretroviral therapy during pregnancy: a study at a regional South African hospital.
001091 Muatale Chileshe [Afrique du Sud] ; Virginia Anne BondBarriers and outcomes: TB patients co-infected with HIV accessing antiretroviral therapy in rural Zambia.
001094 Salome Charalambous [Afrique du Sud] ; Alison D. Grant ; Craig Innes ; Christopher J. Hoffmann ; Rob Dowdeswell ; Jan Pienaar ; Katherine L. Fielding ; Gavin J. ChurchyardAssociation of isoniazid preventive therapy with lower early mortality in individuals on antiretroviral therapy in a workplace programme.
001096 Claire Penn [Afrique du Sud] ; Melanie EvansAssessing the impact of a modified informed consent process in a South African HIV/AIDS research trial.
001099 Karl Peltzer [Afrique du Sud] ; Natalie Friend-Du Preez [Royaume-Uni] ; Shandir Ramlagan [Afrique du Sud] ; Jane Anderson [Royaume-Uni]Antiretroviral treatment adherence among HIV patients in KwaZulu-Natal, South Africa
001113 Heather J. Zar [Afrique du Sud] ; Lesley Workman ; Stanzi M. Le Roux ; Teresa Jennings ; Nomawethu Jele ; Hendrick Simon Schaaf ; Ann Barclay-Loggie ; Chris Mulligan ; David M. Le Roux ; Carl J. Lombard ; Mark F. CottonA randomized controlled trial of intermittent compared with daily cotrimoxazole preventive therapy in HIV-infected children.
001159 Leah Gilbert [Afrique du Sud] ; Liz Walker [Afrique du Sud, Royaume-Uni]‘My biggest fear was that people would reject me once they knew my status…’: stigma as experienced by patients in an HIV/AIDS clinic in Johannesburg, South Africa
001170 Rosalyn C. King [États-Unis] ; Henry N. Fomundam [États-Unis, Afrique du Sud]Remodeling pharmaceutical care in Sub‐Saharan Africa (SSA) amidst human resources challenges and the HIV/AIDS pandemic
001221 Linda Richter [Afrique du Sud] ; Upjeet Chandan ; Tamsen RochatImproving hospital care for young children in the context of HIV/AIDS and poverty.
001315 Suzanne Maman [États-Unis] ; Laurie Abler [États-Unis] ; Lisa Parker [États-Unis] ; Tim Lane [États-Unis] ; Admire Chirowodza [Afrique du Sud] ; Jacob Ntogwisangu [Tanzanie] ; Namtip Srirak [Thaïlande] ; Precious Modiba [Afrique du Sud] ; Oliver Murima [Zimbabwe] ; Katherine Fritz [États-Unis]A comparison of HIV stigma and discrimination in five international sites: The influence of care and treatment resources in high prevalence settings
001319 Busisiwe P. Ncama [Afrique du Sud] ; Patricia A. Mcinerney ; Busisiwe R. Bhengu ; Inge B. Corless ; Dean J. Wantland ; Patrice K. Nicholas ; Chris A. Mcgibbon ; Sheila M. DavisSocial support and medication adherence in HIV disease in KwaZulu-Natal, South Africa.
001402 Leila Mansoor [Afrique du Sud] ; Ros DowseWritten medicines information for South African HIV/AIDS patients: does it enhance understanding of co-trimoxazole therapy?
001627 Janeen Hughes [Afrique du Sud] ; Jennifer Jelsma ; Emilou Maclean ; Marta Darder ; Xolani TiniseThe health-related quality of life of people living with HIV/AIDS.
001707 Malegapuru W. Makgoba [Afrique du Sud]Politics, the media and science in HIV/AIDS: the peril of pseudoscience.
001886 Ernesto Hernández Pérez [Afrique du Sud] ; Halima DawoodStavudine-induced hyperlactatemia/lactic acidosis at a tertiary communicable diseases clinic in South Africa.
001892 Kebede Deribe [Oman] ; Alemeshet Yami [Éthiopie] ; Amare Deribew [Éthiopie] ; Nebiyu Mesfin [Éthiopie] ; Robert Colebunders [Belgique] ; Jean Pierre Van Geertruyden [Belgique] ; Mirkuzie Woldie [Éthiopie] ; Todd Maja [Afrique du Sud]Predictors of Mortality among Tuberculosis/HIV-Coinfected Persons in Southwest Ethiopia: A Case-Control Study.
001898 Ingrid Eshun-Wilson [Afrique du Sud] ; Fiona Havers ; Jean B. Nachega ; Hans W. Prozesky ; Jantjie J. Taljaard ; Michele D. Zeier ; Mark Cotton ; Gary Simon ; Patrick SoentjensEvaluation of paradoxical TB-associated IRIS with the use of standardized case definitions for resource-limited settings.
001899 Verusia Chetty [Afrique du Sud] ; Sonil S. MaharajCollaboration between health professionals in the era of antiretroviral therapy.

Wicri

This area was generated with Dilib version V0.6.32.
Data generation: Mon Nov 13 19:31:10 2017. Site generation: Wed Mar 6 19:14:32 2024